Cold Pain Therapy Market Size, Share, and COVID-19 Impact Analysis By Pharmaceuticals (Gels, Ointments, & Creams, Sprays & Foams, Patches, Roll-ons, and Others) and Devices (Motorized Devices and Non-motorized Devices), By Type (OTC and Prescription), By Application (Musculoskeletal Disorders, Post-trauma & Operative Therapy, and Sport Injuries), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2024-2032

Cold pain therapy, also known as cryotherapy, uses cold materials such as icepack to relieve the pain. It reduces muscle inflammation, swelling, and spasms, by reducing the blood flow in a particular body area. Cold packs, patches, and sprays are primarily used as analgesics as they are effective, inexpensive, and a drugless method for relieving pain.

The rising prevalence of orthopedic diseases and an increasing number of sports injuries are the major factors driving the growth of the cold pain therapy market worldwide.

• For instance, according to data published by World Health Organization (WHO), in 2023, globally around 20-50 million people are injured due to road accidents yearly. Thus, the increase in road accidents leads to a rise in the demand for cold pain therapy products.

In addition, prominent players in the market are focused on mergers and acquisitions to introduce precise pain management solutions to patients and expand their distribution network and supplies across healthcare facilities, which is anticipated to fuel the growth of the market in the near future.

• For instance, in March 2023, Aspen Medical Products, LLC, a provider of pain management solutions, announced its strategic partnership with NICE, a prominent manufacturer in the sports and injury recovery space. The partnership aims to bring more precise recovery and pain management solutions to patients and medical professionals.

However, the wide use of low-cost analgesic pills for immediate pain relief and the lack of limited reimbursement policies for cold pain therapy products in developing economies are the factors hampering the market growth to a certain extent.

Impact of COVID-19 on the Cold Pain Therapy Market

The cold pain therapy market faced a negative impact in 2020 by the COVID-19 pandemic due to the disruptions in supply chains and bio-manufacturing changes coupled with decreased trauma and pain-related hospital admissions. However, the market stabilized in 2021 due to the reopening of manufacturing sites and the lifting of restrictions imposed by the government.

Key Insights

The report will cover the following key insights:

• Prevalence of Orthopedic Diseases - by Key Countries/Regions, 2021/2022.


• New Product Launches, Key Players.


• Overview of Cryotherapies to Improve Health.


• Key Industry Developments – Partnerships, Mergers, and Acquisitions.


• Impact of COVID-19 on the Market.

Analysis by Product

Based on product, the OTC products segment accounted for a significant proportion of the global cold pain therapy market in 2022 owing to the easy product availability and the advent of e-commerce across the globe. Furthermore, a wide range of product launches and technological advancements in product development are projected to drive the growth of the OTC products segment over the forecast period.

• For instance, in April 2022, Jenburkt Pharmaceuticals Ltd. announced the launch of Zixa Strong, a high-performing pain-relief range that delivers long-lasting relief from joint pains.

The prescription products segment is projected to grow at a significant CAGR over the forecast period owing to the growing prevalence of chronic musculoskeletal disorders across the globe. Motorized and non-motorized devices help manage pain, reduce swelling, and ease the healing process after surgery or injury. This factor is responsible for the segment’s growth in the market.

Regional Analysis

To gain extensive insights into the market, Request for Customization

North America dominated the cold pain therapy market in 2022 and is projected to maintain its position over the forecast period. The growth is mainly attributed to the favorable reimbursement scenario in the U.S. and the availability of advanced product technologies, including motorized and non-motorized cold pain therapy devices. In addition, the growing geriatric population is expected to result in a growing prevalence of orthopedic diseases in the region. Which is also expected to fuel the market growth in the region.

• For instance, according to the data published by Population Reference Bureau's fact sheet in 2019, the American population aged 65 and older is estimated to almost double from 52 million in 2018 to 95 million by 2060.

Furthermore, manufacturers with wide distribution networks are projected to fuel the growth of the cold pain therapy market in North America.

In Asia Pacific, the market for cold pain therapy is expected to grow significantly over the forecast period owing to the growing awareness among the population regarding cold pain therapy products and improving healthcare infrastructure in middle and low-income countries.

Key Players Covered

The report will include the profiles of key players such as PharmaSystems Inc., BEIERSDORF, Breg, Inc., DJO, LLC, Johnson & Johnson Services, Inc., Össur, Performance Health, Medline Industries, Inc., Brownmed, Inc., Cardinal Health, and others.

Segmentation

Key Industry Developments

• April 2021: Battle Creek Equipment announced the launch of a new line of Stay-Put cold therapy wraps to treat chronic or acute pain, manage inflammation and accelerate recovery from injury.


• February 2021: Breg, Inc. announced the partnership with Australian-based distributor Club Warehouse to expand the delivery of its premium, high-value orthopedic products in the Australian market, including cold therapy products.